Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERB-041 in active rheumatoid arthritis on background methotrexate
2005-001319-23Phase 2Completed
- Sponsor
- Wyeth
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of prinaberel in rheumatoid arthritis (RA) (4 arms), sponsored by Wyeth. Primary endpoint: ACR20 at 12 weeks. Started Jun 2005; status: completed.
02
Drugs
prinaberel
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2005-001319-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001319-23.